TY - JOUR
T1 - Neuroprotection by the traditional Chinese medicine, Tao-Hong-Si-Wu-Tang, against middle cerebral artery occlusion-induced cerebral ischemia in rats
AU - Sheu, Joen Rong
AU - Wu, Chih Jen
AU - Chen, Jui Tai
AU - Yen, Ting Lin
AU - Jayakumar, Thanasekaran
AU - Chou, Duen Suey
AU - Hsiao, George
PY - 2011
Y1 - 2011
N2 - Tao-Hong-Si-Wu-Tang (THSWT) is a famous traditional Chinese medicine (TMC). In the present study, oral administration of THSWT (0.7 and 1.4g kg -1 day -1) for 14 days before MCAO dose-dependently attenuated focal cerebral ischemia in rats. MCAO-induced focal cerebral ischemia was associated with increases in hypoxia-inducible factor (HIF)-1α , inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α , and active caspase-3 expressions in ischemic regions. These expressions were obviously inhibited by 0.7g kg -1 day -1 THSWT treatment. In addition, THSWT inhibited platelet aggregation stimulated by collagen in washed platelets. In an in vivo study, THSWT (16g kg-1) significantly prolonged platelet plug formation in mice. However, THSWT (20 and 40 g mL -1) did not significantly reduce the electron spin resonance (ESR) signal intensity of hydroxyl radical (OH* ) formation. In conclusion, the most important findings of this study demonstrate for the first time that THSWT possesses potent neuroprotective activity against MCAO-induced focal cerebral ischemia in vivo. This effect may be mediated, at least in part, by the inhibition of both HIF-1α and TNF-α activation, followed by the inhibition of inflammatory responses (i.e., iNOS expression), apoptosis formation (active caspase-3), and platelet activation, resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury.
AB - Tao-Hong-Si-Wu-Tang (THSWT) is a famous traditional Chinese medicine (TMC). In the present study, oral administration of THSWT (0.7 and 1.4g kg -1 day -1) for 14 days before MCAO dose-dependently attenuated focal cerebral ischemia in rats. MCAO-induced focal cerebral ischemia was associated with increases in hypoxia-inducible factor (HIF)-1α , inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF)-α , and active caspase-3 expressions in ischemic regions. These expressions were obviously inhibited by 0.7g kg -1 day -1 THSWT treatment. In addition, THSWT inhibited platelet aggregation stimulated by collagen in washed platelets. In an in vivo study, THSWT (16g kg-1) significantly prolonged platelet plug formation in mice. However, THSWT (20 and 40 g mL -1) did not significantly reduce the electron spin resonance (ESR) signal intensity of hydroxyl radical (OH* ) formation. In conclusion, the most important findings of this study demonstrate for the first time that THSWT possesses potent neuroprotective activity against MCAO-induced focal cerebral ischemia in vivo. This effect may be mediated, at least in part, by the inhibition of both HIF-1α and TNF-α activation, followed by the inhibition of inflammatory responses (i.e., iNOS expression), apoptosis formation (active caspase-3), and platelet activation, resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury.
UR - http://www.scopus.com/inward/record.url?scp=78650718824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650718824&partnerID=8YFLogxK
U2 - 10.1155/2011/803015
DO - 10.1155/2011/803015
M3 - Article
C2 - 21076527
AN - SCOPUS:78650718824
SN - 1741-427X
VL - 2011
JO - Evidence-based Complementary and Alternative Medicine
JF - Evidence-based Complementary and Alternative Medicine
M1 - 803015
ER -